Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs

Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs During the past decade, the price of cancer drugs and the spending for cancer treatments by Medicare have increased dramatically. The author outlines the usual tools Medicare uses to control its spending on drugs and discusses the policies that make cancer drugs a special case and prohibit the regulation of their prices and utilization. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The New England Journal of Medicine The New England Journal of Medicine

Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs

The New England Journal of Medicine , Volume 360 (6): 8 – Feb 5, 2009

Loading next page...
 
/lp/the-new-england-journal-of-medicine/limits-on-medicare-s-ability-to-control-rising-spending-on-cancer-YNmFCcNQrJ

References (29)

Publisher
The New England Journal of Medicine
Copyright
Copyright © 2009 Massachusetts Medical Society. All rights reserved.
ISSN
0028-4793
eISSN
1533-4406
DOI
10.1056/NEJMhpr0807774
pmid
19176475
Publisher site
See Article on Publisher Site

Abstract

During the past decade, the price of cancer drugs and the spending for cancer treatments by Medicare have increased dramatically. The author outlines the usual tools Medicare uses to control its spending on drugs and discusses the policies that make cancer drugs a special case and prohibit the regulation of their prices and utilization.

Journal

The New England Journal of MedicineThe New England Journal of Medicine

Published: Feb 5, 2009

There are no references for this article.